Since the special collection of anticancer drugs in September, it is certain that "Shenyao" will die

With the popularity of "I'm not the God of medicine", there are many questions about the high price of anticancer drugs, and all kinds of discussions about the direct price reduction have been boiling, and the national medical security bureau is ready to go According to the latest news of e drug manager, more than 40 varieties, including AstraZeneca Teresa, have participated in the new round of drug price negotiations, and the reduction is expected to exceed the previous round At the same time, the draft of the notice on carrying out the provincial-level special centralized procurement of anticancer drugs made it clear that by the end of August 2018, each province will issue the implementation plan for the provincial-level special centralized procurement of anticancer drugs; by the end of September 2018, the special procurement will be launched in an all-round way; by the end of 2018, the special centralized procurement will be completed, including online, procurement, clinical use and terminal price Department in place On July 8, the policy information of the National Medical Security Bureau was first published on CCTV news According to the report, the reporter learned from the national medical security bureau that with the gradual implementation of the new regulations on anticancer drugs, relevant departments are actively implementing the follow-up measures to reduce the tax on anticancer drugs, urging them to speed up the price reduction, so that the masses have more sense of access The report clearly pointed out that for how to reduce the price of anti-cancer drugs out of the medical insurance catalog, the medical insurance bureau will carry out access negotiations, negotiate with enterprises to determine a reasonable price and then include it into the catalog, effectively balancing the clinical needs of patients, the reasonable profits of enterprises and the fund bearing capacity In addition to medical insurance negotiations, is there any new action for the newly established national medical insurance bureau? According to the information obtained by e-medicine managers, at present, although the medical bureau rarely publishes information in the media, even up to now, it has not even launched the official website, but in fact, it has prepared some measures, and it has not stopped How can the price be reduced? What is the next move of the medical bureau? Who will be out when cancer drugs enter the medical insurance? According to the first CCTV report, in 2017, 15 cancer drugs with definite curative effect but relatively expensive price were included in the medical insurance catalog, including Herceptin, rituximab and Vanke For the national drug price negotiation led by the Ministry of human resources and social security in 2017, the average decline of negotiated varieties was 44%, and the maximum decline was 70% How much will the negotiation price cut in 2018? There is no doubt that the average decline will exceed 2017 There is no doubt that reducing taxes is a cut for the country to reduce the price of anti-cancer drugs, and there is a greater bargaining chip for this factor From May 1, the State stipulated that the import value-added tax on anti-cancer drugs should be reduced by 3% In addition, the Ministry of finance of the people's Republic of China issued the notice on value added tax policy for anticancer drugs, and also published the first batch of anticancer drugs, including 103 preparations and 51 APIs According to the CCTV report, the next step will be to carry out special bidding procurement, on the basis of fully considering the impact of tax reduction, to achieve price reduction through market competition For new negotiated varieties, special procurement will become a new chip, while the varieties in the list that have not yet entered the medical insurance catalogue will be the focus of this negotiation According to e drug managers, there are more than 40 varieties in communication and negotiation with the National Health Insurance Bureau, including Talisa of asley By the end of September, the special procurement will be launched in an all-round way According to the notice on provincial special centralized procurement of anticancer drugs (Draft for comments) obtained by e drug manager, the state has put forward specific requirements to the medical insurance (Office), health and family planning (Health) committee, human resources and social security department (bureau) of all provinces, autonomous regions, municipalities directly under the central government and Xinjiang Construction Corps According to the notice, in order to implement the decision-making and deployment of the special price reduction of anticancer drugs by the State Council, guarantee the clinical drug demand of cancer patients, and effectively reduce the cost burden of cancer patients, on the basis of the national tax reduction of anticancer drugs, the terminal sales price of anticancer drugs has been significantly reduced, and now it is decided to carry out the special centralized procurement of provincial anticancer drugs nationwide The goal of this work is to implement the special centralized procurement of major disease drugs with the focus on anticancer drugs, optimize the clinical drug use structure, reduce the cost of drug use, further realize the price reduction effect on the basis of tax reduction, and meet the drug demand of the masses The main tasks are: before the end of August 2018, each province will issue the implementation plan of provincial-level special centralized procurement of anticancer drugs; before the end of September 2018, the special centralized procurement will be launched in an all-round way; by the end of 2018, the special centralized procurement will be completed, and the network, procurement, clinical use and terminal prices will be all in place to benefit patients The scope of special centralized procurement is mainly based on the varieties involved in the announcement on reducing drug import tariff issued by the Tariff Commission of the State Council and the notice on value-added tax policy for anticancer drugs issued by the Ministry of finance, the State Administration of Taxation, the General Administration of customs and other departments, basically covering anticancer drugs within the scope of tax reduction That is to say, the products in the list announced previously will become the varieties of special centralized procurement In addition to the varieties that have passed the drug price negotiation before, the remaining varieties will be carried out in this negotiation It is worth noting that in addition to the above-mentioned anti-cancer drug products with tax reduction, the notice also points out that all regions can appropriately expand the scope according to factors such as the amount of drug used, the amount of drug used and the clinical needs For the procurement arrangement of three batches of negotiation varieties (2015, 2017 and 2018), the first two batches of payment standard adjustment will be specially arranged by the State Medical Security Bureau However, the 2018 batch will be purchased online in accordance with the payment standards set by the state According to the notice, the Department in charge of centralized drug purchase shall implement the leading responsibility, clarify the task requirements as soon as possible, formulate the implementation plan and work plan, ensure the progress and implement it well; the procurement implementation organization and platform shall be responsible for timely hanging the network and opening up and organizing the medical organization to sign the contract; the health and health department shall urge the medical organization to sign the procurement contract with the enterprise in time, and unblock the access to the hospital Purchase and sell according to the new price; the medical department shall update the medical insurance settlement system in time to ensure the implementation of the mass reimbursement policy; the drug manufacturer shall predict the supply-demand relationship after the price adjustment to ensure the drug supply The competent departments of drug centralized procurement in each province shall submit the implementation plan and work promotion plan of special centralized procurement to the State Medical Security Bureau and the state health and Health Commission before the end of August, and report the implementation situation before the end of this year In the process of work, major issues shall be reported in a timely manner Although the National Medical Insurance Bureau has not been listed for a long time, the work on medical insurance has not stopped this year In fact, it has been in full swing, and more frequently recently As early as the beginning of February, the topic of "provincial overall planning research on basic medical insurance" was concluded The subject of "provincial overall planning research on basic medical insurance" combs the historical evolution of improving the overall planning level of basic medical insurance in China and the current situation and main methods of the adjustment mechanism of basic medical insurance, and introduces the foreign experience of improving the overall planning level of social medical insurance The main focus of this subject is to emphasize the improvement of the overall planning level of medical insurance fund, to make clear that the responsibilities at all levels should be clear and in place, so as to avoid the following responsibilities becoming more and more vague and weaker due to the improvement of the overall planning level According to the exclusive information of e drug manager, since then, in early May, when the National Medical Insurance Bureau was not established, another kick-off meeting on medical insurance drug price was held in Jiangsu building, Beijing, to prepare for the following bidding and drug price negotiation Hu Jinglin took office after the establishment of the State Medical Security Bureau From June 15 to 16, he went to Sanming City of Fujian Province to investigate the work related to medical security and medical and health system reform Hu Jinglin said in the investigation that Fujian Province and Sanming City adhere to the problem orientation, boldly innovate and resolutely reform, take measures such as integrating urban and rural medical insurance system, reforming drug recruitment mechanism and improving medical insurance payment mode, give full play to the role of "strategic buyer" of medical insurance fund, effectively promote the linkage of medical treatment, medical insurance and medical "three medical" and deepen the reform of medical and health system Samples are provided Hu Jinglin put Sanming as the first place of investigation after the listing of the new medical insurance bureau, which undoubtedly reflects the determination of strengthening the reform of the medical insurance system after the establishment of the new department On July 6, e drug managers learned that the National Medical Security Bureau had organized a "Symposium on drug centralized procurement" in Shanghai hotel According to the notice, relevant heads of the administrative departments in charge of drug bidding and purchase and heads of the drug centralized purchase center from Jiangsu, Zhejiang, Anhui, Jiangxi, Fujian, Shandong, Guangdong and other provinces, Beijing, Shanghai, Tianjin, Chongqing and other cities attended the meeting There are four main contents in the meeting: 1 The recruitment and procurement group of the national medical insurance bureau introduces the requirements of the executive meeting of the State Council for the development of centralized drug procurement; 2 Each province (city) introduces the local centralized procurement work; 3 Each region's suggestions for the next provincial special procurement of anticancer drugs in the medical insurance catalog and the pilot work of centralized drug procurement organized by the state; 4 The leader's speech of the National Medical Insurance Bureau 。 Obviously, the National Medical Security Bureau has conducted in-depth communication with the provinces for special centralized procurement, and the State Council has also put forward clear requirements for the next procurement work of the provinces Therefore, although there are no public documents, the bidding and mining work is already in the dark The change is on the way and will come soon "Shenyao" will be kicked out of the CCTV report and said frankly Next, the anti-cancer drugs will be included in the medical insurance catalog through drug price negotiation, and at the same time, the "fund bearing capacity" will be effectively balanced After a large number of anti-cancer drugs are included in the medical insurance, it is obvious that the medical insurance fund will pay more money for this, but at present, the pressure of medical insurance fund has been known by the industry How to balance "fund affordability"? Obviously, the past "magic medicine" cost a lot Chen Jinfu, deputy director of the State Medical Security Bureau, previously wrote that access conditions and use management should be firmly restricted for "magic drugs" with no significant effectiveness but safety To be blunt, the next step in the adjustment of the medical insurance catalog will be the adjustment of "Shenyao" However, in the past two years, provinces have issued a catalogue of restrictions on the use of auxiliary drugs, which proves that severe restrictions on "Shenyao" have no significant impact on the medical system Therefore, with the support of the catalog data of auxiliary drugs in each province, the strong national medical security bureau will restrict these products more specifically According to e drug managers, the day before the National Medical Security Bureau held a symposium, the Department of drug administration of the health and Health Commission convened experts from all provinces to discuss how to improve the list of essential drugs According to related people, the meeting marks the start of a new round of base drug catalog adjustment The dynamic adjustment mechanism of medical insurance catalogue will be established, and the new basic drug catalogue will be adjusted soon The adjustment of medical insurance and basic medicine will be carried out in an all-round way, and "Shenyao" will face a double attack, and will surely become the outcomer in this great reform